| Tretinoin | Approved Investigational Nutraceutical | BYSL | 705 |
downregulated | Tretinoin results in decreased expression of BYSL mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BZW2 | 28969 |
downregulated | Tretinoin results in decreased expression of BZW2 mRNA | 7p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | C1QBP | 708 |
downregulated | Tretinoin results in decreased expression of C1QBP mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | C1QL1 | 10882 |
downregulated | Tretinoin results in decreased expression of C1QL1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | C1QTNF3 | 114899 |
upregulated | Tretinoin results in increased expression of C1QTNF3 mRNA | 5p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | C1QTNF4 | 114900 |
upregulated | Tretinoin results in increased expression of C1QTNF4 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | C1R | 715 |
upregulated | Tretinoin results in increased expression of C1R mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | C1S | 716 |
upregulated | Tretinoin results in increased expression of C1S mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CA10 | 56934 |
upregulated | Tretinoin results in increased expression of CA10 mRNA | 17q21.33-q22 | |
| Tretinoin | Approved Investigational Nutraceutical | CA11 | 770 |
downregulated | Tretinoin results in decreased expression of CA11 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CA2 | 760 |
upregulated | Tretinoin results in increased expression of CA2 mRNA | 8q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CA3 | 761 |
upregulated | Tretinoin results in increased expression of CA3 mRNA | 8q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CA6 | 765 |
upregulated | Tretinoin results in increased expression of CA6 mRNA | 1p36.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CABLES1 | 91768 |
downregulated | Tretinoin results in decreased expression of CABLES1 mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CABYR | 26256 |
downregulated | Tretinoin results in decreased expression of CABYR mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CACNA1A | 773 |
downregulated | Tretinoin results in decreased expression of CACNA1A mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CACNA1D | 776 |
upregulated | Tretinoin results in increased expression of CACNA1D mRNA | 3p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CACNB1 | 782 |
downregulated | Tretinoin results in decreased expression of CACNB1 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CACNG1 | 786 |
upregulated | Tretinoin results in increased expression of CACNG1 mRNA | 17q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CADM1 | 23705 |
upregulated | Tretinoin results in increased expression of CADM1 mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CADM2 | 253559 |
downregulated | Tretinoin results in decreased expression of CADM2 mRNA | 3p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CADPS | 8618 |
upregulated | Tretinoin results in increased expression of CADPS mRNA | 3p14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CALB1 | 793 |
downregulated | Tretinoin results in decreased expression of CALB1 mRNA | 8q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CALCA | 796 |
upregulated | Tretinoin results in increased expression of CALCA mRNA | 11p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CALHM2 | 51063 |
downregulated | Tretinoin results in decreased expression of CALHM2 mRNA | 10q24.33 | |